Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

V Jovanovic

Showing results (81-90 of 96) with videos related to

Pageof 10
Sort By:
Leukemia|November 7, 2008
Detection and molecular monitoring of FIP1L1-PDGFRA-positive disease by analysis of patient-specific genomic DNA fusion junctionsJ Score, C Walz, J V Jovanovic, et al.
Healthcare (Basel, Switzerland)|September 25, 2019
Correlation of Clinicopathological Characteristics of Breast Carcinoma and DepressionMilena B Ilic, Slobodanka Lj Mitrovic, Milena S Vuletic, et al.
Blood|February 5, 2014
Loss of imprinting at the 14q32 domain is associated with microRNA overexpression in acute promyelocytic leukemiaFloriana Manodoro, Jacek Marzec, Tracy Chaplin, et al.
European Review for Medical and Pharmacological Sciences|February 18, 2022
Predicting no-reflow phenomenon prior to primary percutaneous coronary intervention using a novel probability risk score derived from clinical and angiographic parametersZ Stajic, D Milicevic, S Kafedzic, et al.
Leukemia|December 11, 2012
Inclusion of chemotherapy in addition to anthracycline in the treatment of acute promyelocytic leukaemia does not improve outcomes: results of the MRC AML15 trialA K Burnett, R K Hills, D Grimwade, et al.
Healthcare (Basel, Switzerland)|September 28, 2021
Breast Cancer and p16: Role in Proliferation, Malignant Transformation and ProgressionDalibor V Jovanovic, Slobodanka L Mitrovic, Milos Z Milosavljevic, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 15, 2007
RARalpha-PLZF overcomes PLZF-mediated repression of CRABPI, contributing to retinoid resistance in t(11;17) acute promyelocytic leukemiaFabien Guidez, Sarah Parks, Henna Wong, et al.
Leukemia|April 16, 2011
Development of standardized approaches to reporting of minimal residual disease data using a reporting software package designed within the European LeukemiaNetM Østergaard, C G Nyvold, J V Jovanovic, et al.
Annals of Noninvasive Electrocardiology : the Official Journal of the International Society for Holter and Noninvasive Electrocardiology, Inc|December 30, 2014
Clinical implementation of cardiac resynchronization therapy-regional disparities across selected ESC member countriesR Hatala, M Lunati, V Calvi, et al.
Leukemia|November 23, 2016
The cryptic IRF2BP2-RARA fusion transforms hematopoietic stem/progenitor cells and induces retinoid-sensitive acute promyelocytic leukemiaJ V Jovanovic, M C Chillón, C Vincent-Fabert, et al.
Pageof 10

Showing results (81-90 of 96) with videos related to

Sort By:
Pageof 10
Leukemia|November 7, 2008
Detection and molecular monitoring of FIP1L1-PDGFRA-positive disease by analysis of patient-specific genomic DNA fusion junctionsJ Score, C Walz, J V Jovanovic, et al.
Healthcare (Basel, Switzerland)|September 25, 2019
Correlation of Clinicopathological Characteristics of Breast Carcinoma and DepressionMilena B Ilic, Slobodanka Lj Mitrovic, Milena S Vuletic, et al.
Blood|February 5, 2014
Loss of imprinting at the 14q32 domain is associated with microRNA overexpression in acute promyelocytic leukemiaFloriana Manodoro, Jacek Marzec, Tracy Chaplin, et al.
European Review for Medical and Pharmacological Sciences|February 18, 2022
Predicting no-reflow phenomenon prior to primary percutaneous coronary intervention using a novel probability risk score derived from clinical and angiographic parametersZ Stajic, D Milicevic, S Kafedzic, et al.
Leukemia|December 11, 2012
Inclusion of chemotherapy in addition to anthracycline in the treatment of acute promyelocytic leukaemia does not improve outcomes: results of the MRC AML15 trialA K Burnett, R K Hills, D Grimwade, et al.
Healthcare (Basel, Switzerland)|September 28, 2021
Breast Cancer and p16: Role in Proliferation, Malignant Transformation and ProgressionDalibor V Jovanovic, Slobodanka L Mitrovic, Milos Z Milosavljevic, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 15, 2007
RARalpha-PLZF overcomes PLZF-mediated repression of CRABPI, contributing to retinoid resistance in t(11;17) acute promyelocytic leukemiaFabien Guidez, Sarah Parks, Henna Wong, et al.
Leukemia|April 16, 2011
Development of standardized approaches to reporting of minimal residual disease data using a reporting software package designed within the European LeukemiaNetM Østergaard, C G Nyvold, J V Jovanovic, et al.
Annals of Noninvasive Electrocardiology : the Official Journal of the International Society for Holter and Noninvasive Electrocardiology, Inc|December 30, 2014
Clinical implementation of cardiac resynchronization therapy-regional disparities across selected ESC member countriesR Hatala, M Lunati, V Calvi, et al.
Leukemia|November 23, 2016
The cryptic IRF2BP2-RARA fusion transforms hematopoietic stem/progenitor cells and induces retinoid-sensitive acute promyelocytic leukemiaJ V Jovanovic, M C Chillón, C Vincent-Fabert, et al.
Pageof 10